ADIPOQ and obesity disorder: Prior studies have indicated that adiponectin secretion is paradoxically decreased in obesity, likely as a result of the inhibitory effects of inflammatory factors secreted by hypertrophic adipocytes (i.e., as in obesity) (3–5).